nodes	percent_of_prediction	percent_of_DWPC	metapath
Modafinil—CYP3A5—prostate cancer	0.155	0.473	CbGaD
Modafinil—CYP2C19—prostate cancer	0.106	0.322	CbGaD
Modafinil—CYP3A4—prostate cancer	0.0673	0.205	CbGaD
Modafinil—CYP3A5—Flutamide—prostate cancer	0.0226	0.0557	CbGbCtD
Modafinil—CYP2C19—Bicalutamide—prostate cancer	0.022	0.0542	CbGbCtD
Modafinil—CYP2C19—Nilutamide—prostate cancer	0.022	0.0542	CbGbCtD
Modafinil—CYP2B6—Estrone—prostate cancer	0.0207	0.0511	CbGbCtD
Modafinil—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0202	0.0499	CbGbCtD
Modafinil—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0184	0.0455	CbGbCtD
Modafinil—CYP2C9—Nilutamide—prostate cancer	0.0183	0.045	CbGbCtD
Modafinil—CYP2C9—Bicalutamide—prostate cancer	0.0183	0.045	CbGbCtD
Modafinil—CYP2C19—Flutamide—prostate cancer	0.0182	0.0449	CbGbCtD
Modafinil—ADRA1B—vas deferens—prostate cancer	0.0174	0.588	CbGeAlD
Modafinil—CYP1A2—Flutamide—prostate cancer	0.0168	0.0414	CbGbCtD
Modafinil—CYP3A5—Cabazitaxel—prostate cancer	0.0167	0.0412	CbGbCtD
Modafinil—CYP3A5—Estrone—prostate cancer	0.0163	0.0402	CbGbCtD
Modafinil—CYP1A2—Estrone—prostate cancer	0.0121	0.0299	CbGbCtD
Modafinil—CYP2C9—Estrone—prostate cancer	0.0109	0.027	CbGbCtD
Modafinil—CYP3A4—Bicalutamide—prostate cancer	0.0106	0.0262	CbGbCtD
Modafinil—CYP3A4—Estramustine—prostate cancer	0.00987	0.0243	CbGbCtD
Modafinil—CYP3A5—Estradiol—prostate cancer	0.00937	0.0231	CbGbCtD
Modafinil—CYP3A4—Flutamide—prostate cancer	0.00879	0.0217	CbGbCtD
Modafinil—CYP3A4—Abiraterone—prostate cancer	0.00879	0.0217	CbGbCtD
Modafinil—CYP2C9—Capecitabine—prostate cancer	0.00829	0.0204	CbGbCtD
Modafinil—CYP1A2—Conjugated Estrogens—prostate cancer	0.00794	0.0196	CbGbCtD
Modafinil—CYP2C19—Estradiol—prostate cancer	0.00755	0.0186	CbGbCtD
Modafinil—CYP1A2—Estradiol—prostate cancer	0.00697	0.0172	CbGbCtD
Modafinil—CYP3A4—Cabazitaxel—prostate cancer	0.00651	0.0161	CbGbCtD
Modafinil—CYP2C19—Prednisone—prostate cancer	0.0065	0.016	CbGbCtD
Modafinil—CYP3A4—Estrone—prostate cancer	0.00636	0.0157	CbGbCtD
Modafinil—CYP2C9—Estradiol—prostate cancer	0.00628	0.0155	CbGbCtD
Modafinil—CYP3A5—Etoposide—prostate cancer	0.00611	0.0151	CbGbCtD
Modafinil—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00567	0.014	CbGbCtD
Modafinil—CYP3A5—Docetaxel—prostate cancer	0.00559	0.0138	CbGbCtD
Modafinil—CYP2B6—Doxorubicin—prostate cancer	0.00529	0.0131	CbGbCtD
Modafinil—CYP1A2—Etoposide—prostate cancer	0.00455	0.0112	CbGbCtD
Modafinil—CYP3A4—Conjugated Estrogens—prostate cancer	0.00416	0.0103	CbGbCtD
Modafinil—CYP3A4—Mitoxantrone—prostate cancer	0.00378	0.00933	CbGbCtD
Modafinil—CYP3A4—Estradiol—prostate cancer	0.00365	0.00901	CbGbCtD
Modafinil—CYP3A4—Prednisone—prostate cancer	0.00314	0.00775	CbGbCtD
Modafinil—CYP2C19—urine—prostate cancer	0.00246	0.0832	CbGeAlD
Modafinil—CYP3A4—Etoposide—prostate cancer	0.00238	0.00588	CbGbCtD
Modafinil—CYP3A4—Docetaxel—prostate cancer	0.00218	0.00538	CbGbCtD
Modafinil—CYP1A2—urine—prostate cancer	0.00201	0.0679	CbGeAlD
Modafinil—CYP2C9—urine—prostate cancer	0.00191	0.0645	CbGeAlD
Modafinil—CYP3A4—Doxorubicin—prostate cancer	0.00163	0.00401	CbGbCtD
Modafinil—CYP3A4—urine—prostate cancer	0.00145	0.0492	CbGeAlD
Modafinil—ADRA1B—renal system—prostate cancer	0.00106	0.0358	CbGeAlD
Modafinil—CYP3A5—prostate gland—prostate cancer	0.000695	0.0235	CbGeAlD
Modafinil—Cyclizine—SULT1E1—prostate cancer	0.000519	0.144	CrCbGaD
Modafinil—SLC6A3—testis—prostate cancer	0.000512	0.0173	CbGeAlD
Modafinil—CYP1A2—renal system—prostate cancer	0.000491	0.0166	CbGeAlD
Modafinil—CYP3A5—renal system—prostate cancer	0.000474	0.016	CbGeAlD
Modafinil—CYP2B6—renal system—prostate cancer	0.000471	0.0159	CbGeAlD
Modafinil—CYP3A4—renal system—prostate cancer	0.000356	0.012	CbGeAlD
Modafinil—CYP2B6—testis—prostate cancer	0.000304	0.0103	CbGeAlD
Modafinil—Carbamazepine—RALBP1—prostate cancer	0.000215	0.0597	CrCbGaD
Modafinil—Bifonazole—CYP17A1—prostate cancer	0.000175	0.0487	CrCbGaD
Modafinil—Warfarin—CYP2C18—prostate cancer	0.000118	0.0327	CrCbGaD
Modafinil—Phenoxybenzamine—SLC22A3—prostate cancer	9.11e-05	0.0253	CrCbGaD
Modafinil—Bifonazole—CYP19A1—prostate cancer	8.92e-05	0.0248	CrCbGaD
Modafinil—Ketoprofen—CXCL8—prostate cancer	8.71e-05	0.0242	CrCbGaD
Modafinil—Fosphenytoin—CYP2C19—prostate cancer	8.7e-05	0.0241	CrCbGaD
Modafinil—Phenytoin—CYP2C18—prostate cancer	8.57e-05	0.0238	CrCbGaD
Modafinil—Oxcarbazepine—CYP3A5—prostate cancer	8.52e-05	0.0236	CrCbGaD
Modafinil—Levomethadyl Acetate—CYP3A5—prostate cancer	7.28e-05	0.0202	CrCbGaD
Modafinil—Diphenhydramine—CYP2C18—prostate cancer	6.71e-05	0.0186	CrCbGaD
Modafinil—Levomethadyl Acetate—CYP19A1—prostate cancer	6.71e-05	0.0186	CrCbGaD
Modafinil—Bifonazole—CYP2E1—prostate cancer	6.65e-05	0.0185	CrCbGaD
Modafinil—Bifonazole—CYP2C19—prostate cancer	6.59e-05	0.0183	CrCbGaD
Modafinil—Phenoxybenzamine—SLC22A1—prostate cancer	6.53e-05	0.0181	CrCbGaD
Modafinil—Methadone—CYP2C18—prostate cancer	6.48e-05	0.018	CrCbGaD
Modafinil—Nepafenac—PTGS2—prostate cancer	6.27e-05	0.0174	CrCbGaD
Modafinil—Fentanyl—CYP3A5—prostate cancer	6.22e-05	0.0173	CrCbGaD
Modafinil—Cinnarizine—CYP2A6—prostate cancer	5.96e-05	0.0165	CrCbGaD
Modafinil—Benzatropine—CYP2C19—prostate cancer	5.85e-05	0.0162	CrCbGaD
Modafinil—Carbamazepine—CYP3A5—prostate cancer	5.81e-05	0.0161	CrCbGaD
Modafinil—Oxcarbazepine—CYP2C19—prostate cancer	5.8e-05	0.0161	CrCbGaD
Modafinil—Phenytoin—CYP3A5—prostate cancer	5.64e-05	0.0157	CrCbGaD
Modafinil—Fosphenytoin—CYP3A4—prostate cancer	5.53e-05	0.0153	CrCbGaD
Modafinil—Diphenhydramine—SLC22A1—prostate cancer	5.48e-05	0.0152	CrCbGaD
Modafinil—Warfarin—CYP2C19—prostate cancer	5.29e-05	0.0147	CrCbGaD
Modafinil—Warfarin—CYP1A1—prostate cancer	5.27e-05	0.0146	CrCbGaD
Modafinil—Oxaprozin—PTGS2—prostate cancer	5.21e-05	0.0144	CrCbGaD
Modafinil—Fenoprofen—PTGS2—prostate cancer	4.3e-05	0.0119	CrCbGaD
Modafinil—Methadone—CYP3A5—prostate cancer	4.27e-05	0.0118	CrCbGaD
Modafinil—Bifonazole—CYP3A4—prostate cancer	4.19e-05	0.0116	CrCbGaD
Modafinil—Cinnarizine—CYP1A1—prostate cancer	4.17e-05	0.0116	CrCbGaD
Modafinil—Phenoxybenzamine—ADRB2—prostate cancer	4.17e-05	0.0116	CrCbGaD
Modafinil—Carbamazepine—CYP2C19—prostate cancer	3.95e-05	0.011	CrCbGaD
Modafinil—Methadone—CYP19A1—prostate cancer	3.93e-05	0.0109	CrCbGaD
Modafinil—Phenytoin—CYP2C19—prostate cancer	3.84e-05	0.0107	CrCbGaD
Modafinil—Phenprocoumon—CYP3A4—prostate cancer	3.79e-05	0.0105	CrCbGaD
Modafinil—Atomoxetine—CYP2C19—prostate cancer	3.72e-05	0.0103	CrCbGaD
Modafinil—Oxcarbazepine—CYP3A4—prostate cancer	3.69e-05	0.0102	CrCbGaD
Modafinil—Phenylbutazone—CYP3A4—prostate cancer	3.52e-05	0.00975	CrCbGaD
Modafinil—Phenylbutazone—PTGS2—prostate cancer	3.44e-05	0.00955	CrCbGaD
Modafinil—Warfarin—CYP3A4—prostate cancer	3.36e-05	0.00933	CrCbGaD
Modafinil—Levomethadyl Acetate—CYP3A4—prostate cancer	3.15e-05	0.00874	CrCbGaD
Modafinil—Hypertension—Prednisone—prostate cancer	3.07e-05	0.000205	CcSEcCtD
Modafinil—Rash—Mitoxantrone—prostate cancer	3.07e-05	0.000205	CcSEcCtD
Modafinil—Dermatitis—Mitoxantrone—prostate cancer	3.06e-05	0.000205	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Docetaxel—prostate cancer	3.06e-05	0.000205	CcSEcCtD
Modafinil—Headache—Mitoxantrone—prostate cancer	3.05e-05	0.000204	CcSEcCtD
Modafinil—Hypotension—Capecitabine—prostate cancer	3.04e-05	0.000203	CcSEcCtD
Modafinil—Insomnia—Docetaxel—prostate cancer	3.04e-05	0.000203	CcSEcCtD
Modafinil—Arthralgia—Prednisone—prostate cancer	3.03e-05	0.000202	CcSEcCtD
Modafinil—Myalgia—Prednisone—prostate cancer	3.03e-05	0.000202	CcSEcCtD
Modafinil—Paraesthesia—Docetaxel—prostate cancer	3.02e-05	0.000202	CcSEcCtD
Modafinil—Erythema multiforme—Epirubicin—prostate cancer	3.02e-05	0.000202	CcSEcCtD
Modafinil—Anxiety—Prednisone—prostate cancer	3.01e-05	0.000201	CcSEcCtD
Modafinil—Diphenhydramine—CYP2C19—prostate cancer	3.01e-05	0.00835	CrCbGaD
Modafinil—Bradycardia—Doxorubicin—prostate cancer	3.01e-05	0.000201	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	3e-05	0.000201	CcSEcCtD
Modafinil—Dyspnoea—Docetaxel—prostate cancer	3e-05	0.0002	CcSEcCtD
Modafinil—Somnolence—Docetaxel—prostate cancer	2.99e-05	0.0002	CcSEcCtD
Modafinil—Discomfort—Prednisone—prostate cancer	2.99e-05	0.0002	CcSEcCtD
Modafinil—Hypersensitivity—Etoposide—prostate cancer	2.98e-05	0.000199	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Capecitabine—prostate cancer	2.97e-05	0.000198	CcSEcCtD
Modafinil—Cardiac disorder—Epirubicin—prostate cancer	2.96e-05	0.000198	CcSEcCtD
Modafinil—Rhinitis—Doxorubicin—prostate cancer	2.96e-05	0.000198	CcSEcCtD
Modafinil—Dyspepsia—Docetaxel—prostate cancer	2.96e-05	0.000198	CcSEcCtD
Modafinil—Insomnia—Capecitabine—prostate cancer	2.94e-05	0.000197	CcSEcCtD
Modafinil—Pharyngitis—Doxorubicin—prostate cancer	2.93e-05	0.000196	CcSEcCtD
Modafinil—Paraesthesia—Capecitabine—prostate cancer	2.92e-05	0.000195	CcSEcCtD
Modafinil—Decreased appetite—Docetaxel—prostate cancer	2.92e-05	0.000195	CcSEcCtD
Modafinil—Urinary tract disorder—Doxorubicin—prostate cancer	2.92e-05	0.000195	CcSEcCtD
Modafinil—Oedema peripheral—Doxorubicin—prostate cancer	2.91e-05	0.000194	CcSEcCtD
Modafinil—Methadone—CYP2C19—prostate cancer	2.9e-05	0.00806	CrCbGaD
Modafinil—Gastrointestinal disorder—Docetaxel—prostate cancer	2.9e-05	0.000194	CcSEcCtD
Modafinil—Asthenia—Etoposide—prostate cancer	2.9e-05	0.000194	CcSEcCtD
Modafinil—Connective tissue disorder—Doxorubicin—prostate cancer	2.9e-05	0.000194	CcSEcCtD
Modafinil—Dyspnoea—Capecitabine—prostate cancer	2.9e-05	0.000194	CcSEcCtD
Modafinil—Anaphylactic shock—Prednisone—prostate cancer	2.9e-05	0.000194	CcSEcCtD
Modafinil—Oedema—Prednisone—prostate cancer	2.9e-05	0.000194	CcSEcCtD
Modafinil—Fatigue—Docetaxel—prostate cancer	2.9e-05	0.000194	CcSEcCtD
Modafinil—Angiopathy—Epirubicin—prostate cancer	2.9e-05	0.000194	CcSEcCtD
Modafinil—Urethral disorder—Doxorubicin—prostate cancer	2.9e-05	0.000193	CcSEcCtD
Modafinil—Nausea—Mitoxantrone—prostate cancer	2.89e-05	0.000193	CcSEcCtD
Modafinil—Immune system disorder—Epirubicin—prostate cancer	2.88e-05	0.000193	CcSEcCtD
Modafinil—Infection—Prednisone—prostate cancer	2.88e-05	0.000193	CcSEcCtD
Modafinil—Mediastinal disorder—Epirubicin—prostate cancer	2.88e-05	0.000192	CcSEcCtD
Modafinil—Constipation—Docetaxel—prostate cancer	2.88e-05	0.000192	CcSEcCtD
Modafinil—Pain—Docetaxel—prostate cancer	2.88e-05	0.000192	CcSEcCtD
Modafinil—Orphenadrine—CYP2E1—prostate cancer	2.87e-05	0.00797	CrCbGaD
Modafinil—Dyspepsia—Capecitabine—prostate cancer	2.87e-05	0.000192	CcSEcCtD
Modafinil—Chills—Epirubicin—prostate cancer	2.86e-05	0.000191	CcSEcCtD
Modafinil—Pruritus—Etoposide—prostate cancer	2.86e-05	0.000191	CcSEcCtD
Modafinil—Shock—Prednisone—prostate cancer	2.85e-05	0.000191	CcSEcCtD
Modafinil—Arrhythmia—Epirubicin—prostate cancer	2.85e-05	0.000191	CcSEcCtD
Modafinil—Visual impairment—Doxorubicin—prostate cancer	2.85e-05	0.00019	CcSEcCtD
Modafinil—Nervous system disorder—Prednisone—prostate cancer	2.84e-05	0.00019	CcSEcCtD
Modafinil—Tachycardia—Prednisone—prostate cancer	2.83e-05	0.000189	CcSEcCtD
Modafinil—Decreased appetite—Capecitabine—prostate cancer	2.83e-05	0.000189	CcSEcCtD
Modafinil—Skin disorder—Prednisone—prostate cancer	2.82e-05	0.000188	CcSEcCtD
Modafinil—Gastrointestinal disorder—Capecitabine—prostate cancer	2.81e-05	0.000188	CcSEcCtD
Modafinil—Fatigue—Capecitabine—prostate cancer	2.81e-05	0.000188	CcSEcCtD
Modafinil—Hyperhidrosis—Prednisone—prostate cancer	2.8e-05	0.000187	CcSEcCtD
Modafinil—Mental disorder—Epirubicin—prostate cancer	2.8e-05	0.000187	CcSEcCtD
Modafinil—Erythema multiforme—Doxorubicin—prostate cancer	2.79e-05	0.000187	CcSEcCtD
Modafinil—Constipation—Capecitabine—prostate cancer	2.78e-05	0.000186	CcSEcCtD
Modafinil—Pain—Capecitabine—prostate cancer	2.78e-05	0.000186	CcSEcCtD
Modafinil—Malnutrition—Epirubicin—prostate cancer	2.78e-05	0.000186	CcSEcCtD
Modafinil—Feeling abnormal—Docetaxel—prostate cancer	2.77e-05	0.000185	CcSEcCtD
Modafinil—Diarrhoea—Etoposide—prostate cancer	2.77e-05	0.000185	CcSEcCtD
Modafinil—Anorexia—Prednisone—prostate cancer	2.76e-05	0.000185	CcSEcCtD
Modafinil—Gastrointestinal pain—Docetaxel—prostate cancer	2.75e-05	0.000184	CcSEcCtD
Modafinil—Cardiac disorder—Doxorubicin—prostate cancer	2.74e-05	0.000183	CcSEcCtD
Modafinil—Flatulence—Epirubicin—prostate cancer	2.74e-05	0.000183	CcSEcCtD
Modafinil—Tension—Epirubicin—prostate cancer	2.73e-05	0.000182	CcSEcCtD
Modafinil—Dextropropoxyphene—CYP3A4—prostate cancer	2.72e-05	0.00755	CrCbGaD
Modafinil—Dysgeusia—Epirubicin—prostate cancer	2.72e-05	0.000182	CcSEcCtD
Modafinil—Nervousness—Epirubicin—prostate cancer	2.7e-05	0.00018	CcSEcCtD
Modafinil—Fentanyl—CYP3A4—prostate cancer	2.69e-05	0.00747	CrCbGaD
Modafinil—Back pain—Epirubicin—prostate cancer	2.69e-05	0.00018	CcSEcCtD
Modafinil—Feeling abnormal—Capecitabine—prostate cancer	2.68e-05	0.000179	CcSEcCtD
Modafinil—Angiopathy—Doxorubicin—prostate cancer	2.68e-05	0.000179	CcSEcCtD
Modafinil—Dizziness—Etoposide—prostate cancer	2.68e-05	0.000179	CcSEcCtD
Modafinil—Muscle spasms—Epirubicin—prostate cancer	2.67e-05	0.000179	CcSEcCtD
Modafinil—Immune system disorder—Doxorubicin—prostate cancer	2.67e-05	0.000178	CcSEcCtD
Modafinil—Gastrointestinal pain—Capecitabine—prostate cancer	2.66e-05	0.000178	CcSEcCtD
Modafinil—Mediastinal disorder—Doxorubicin—prostate cancer	2.66e-05	0.000178	CcSEcCtD
Modafinil—Body temperature increased—Docetaxel—prostate cancer	2.66e-05	0.000178	CcSEcCtD
Modafinil—Abdominal pain—Docetaxel—prostate cancer	2.66e-05	0.000178	CcSEcCtD
Modafinil—Chills—Doxorubicin—prostate cancer	2.65e-05	0.000177	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Prednisone—prostate cancer	2.64e-05	0.000177	CcSEcCtD
Modafinil—Arrhythmia—Doxorubicin—prostate cancer	2.64e-05	0.000176	CcSEcCtD
Modafinil—Insomnia—Prednisone—prostate cancer	2.62e-05	0.000175	CcSEcCtD
Modafinil—Paraesthesia—Prednisone—prostate cancer	2.6e-05	0.000174	CcSEcCtD
Modafinil—Mental disorder—Doxorubicin—prostate cancer	2.59e-05	0.000173	CcSEcCtD
Modafinil—Urticaria—Capecitabine—prostate cancer	2.59e-05	0.000173	CcSEcCtD
Modafinil—Ill-defined disorder—Epirubicin—prostate cancer	2.58e-05	0.000172	CcSEcCtD
Modafinil—Body temperature increased—Capecitabine—prostate cancer	2.57e-05	0.000172	CcSEcCtD
Modafinil—Abdominal pain—Capecitabine—prostate cancer	2.57e-05	0.000172	CcSEcCtD
Modafinil—Vomiting—Etoposide—prostate cancer	2.57e-05	0.000172	CcSEcCtD
Modafinil—Malnutrition—Doxorubicin—prostate cancer	2.57e-05	0.000172	CcSEcCtD
Modafinil—Anaemia—Epirubicin—prostate cancer	2.57e-05	0.000172	CcSEcCtD
Modafinil—Agitation—Epirubicin—prostate cancer	2.55e-05	0.000171	CcSEcCtD
Modafinil—Dyspepsia—Prednisone—prostate cancer	2.55e-05	0.000171	CcSEcCtD
Modafinil—Rash—Etoposide—prostate cancer	2.55e-05	0.00017	CcSEcCtD
Modafinil—Dermatitis—Etoposide—prostate cancer	2.55e-05	0.00017	CcSEcCtD
Modafinil—Ketoprofen—PTGS2—prostate cancer	2.54e-05	0.00705	CrCbGaD
Modafinil—Headache—Etoposide—prostate cancer	2.53e-05	0.000169	CcSEcCtD
Modafinil—Flatulence—Doxorubicin—prostate cancer	2.53e-05	0.000169	CcSEcCtD
Modafinil—Tension—Doxorubicin—prostate cancer	2.52e-05	0.000169	CcSEcCtD
Modafinil—Decreased appetite—Prednisone—prostate cancer	2.52e-05	0.000168	CcSEcCtD
Modafinil—Dysgeusia—Doxorubicin—prostate cancer	2.52e-05	0.000168	CcSEcCtD
Modafinil—Carbamazepine—CYP3A4—prostate cancer	2.51e-05	0.00697	CrCbGaD
Modafinil—Malaise—Epirubicin—prostate cancer	2.51e-05	0.000167	CcSEcCtD
Modafinil—Fatigue—Prednisone—prostate cancer	2.5e-05	0.000167	CcSEcCtD
Modafinil—Nervousness—Doxorubicin—prostate cancer	2.5e-05	0.000167	CcSEcCtD
Modafinil—Vertigo—Epirubicin—prostate cancer	2.5e-05	0.000167	CcSEcCtD
Modafinil—Syncope—Epirubicin—prostate cancer	2.49e-05	0.000167	CcSEcCtD
Modafinil—Back pain—Doxorubicin—prostate cancer	2.49e-05	0.000166	CcSEcCtD
Modafinil—Constipation—Prednisone—prostate cancer	2.48e-05	0.000166	CcSEcCtD
Modafinil—Hypersensitivity—Docetaxel—prostate cancer	2.48e-05	0.000166	CcSEcCtD
Modafinil—Muscle spasms—Doxorubicin—prostate cancer	2.47e-05	0.000165	CcSEcCtD
Modafinil—Palpitations—Epirubicin—prostate cancer	2.46e-05	0.000164	CcSEcCtD
Modafinil—Loss of consciousness—Epirubicin—prostate cancer	2.44e-05	0.000163	CcSEcCtD
Modafinil—Phenytoin—CYP3A4—prostate cancer	2.44e-05	0.00678	CrCbGaD
Modafinil—Cough—Epirubicin—prostate cancer	2.43e-05	0.000162	CcSEcCtD
Modafinil—Asthenia—Docetaxel—prostate cancer	2.41e-05	0.000161	CcSEcCtD
Modafinil—Convulsion—Epirubicin—prostate cancer	2.41e-05	0.000161	CcSEcCtD
Modafinil—Nausea—Etoposide—prostate cancer	2.4e-05	0.000161	CcSEcCtD
Modafinil—Hypertension—Epirubicin—prostate cancer	2.4e-05	0.00016	CcSEcCtD
Modafinil—Hypersensitivity—Capecitabine—prostate cancer	2.4e-05	0.00016	CcSEcCtD
Modafinil—Feeling abnormal—Prednisone—prostate cancer	2.39e-05	0.00016	CcSEcCtD
Modafinil—Benzphetamine—CYP3A4—prostate cancer	2.39e-05	0.00662	CrCbGaD
Modafinil—Ill-defined disorder—Doxorubicin—prostate cancer	2.39e-05	0.000159	CcSEcCtD
Modafinil—Pruritus—Docetaxel—prostate cancer	2.38e-05	0.000159	CcSEcCtD
Modafinil—Anaemia—Doxorubicin—prostate cancer	2.38e-05	0.000159	CcSEcCtD
Modafinil—Gastrointestinal pain—Prednisone—prostate cancer	2.37e-05	0.000158	CcSEcCtD
Modafinil—Atomoxetine—CYP3A4—prostate cancer	2.37e-05	0.00657	CrCbGaD
Modafinil—Myalgia—Epirubicin—prostate cancer	2.37e-05	0.000158	CcSEcCtD
Modafinil—Arthralgia—Epirubicin—prostate cancer	2.37e-05	0.000158	CcSEcCtD
Modafinil—Chest pain—Epirubicin—prostate cancer	2.37e-05	0.000158	CcSEcCtD
Modafinil—Agitation—Doxorubicin—prostate cancer	2.36e-05	0.000158	CcSEcCtD
Modafinil—Anxiety—Epirubicin—prostate cancer	2.36e-05	0.000158	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	2.35e-05	0.000157	CcSEcCtD
Modafinil—Discomfort—Epirubicin—prostate cancer	2.34e-05	0.000156	CcSEcCtD
Modafinil—Asthenia—Capecitabine—prostate cancer	2.34e-05	0.000156	CcSEcCtD
Modafinil—Malaise—Doxorubicin—prostate cancer	2.32e-05	0.000155	CcSEcCtD
Modafinil—Dry mouth—Epirubicin—prostate cancer	2.31e-05	0.000155	CcSEcCtD
Modafinil—Vertigo—Doxorubicin—prostate cancer	2.31e-05	0.000154	CcSEcCtD
Modafinil—Syncope—Doxorubicin—prostate cancer	2.31e-05	0.000154	CcSEcCtD
Modafinil—Urticaria—Prednisone—prostate cancer	2.3e-05	0.000154	CcSEcCtD
Modafinil—Pruritus—Capecitabine—prostate cancer	2.3e-05	0.000154	CcSEcCtD
Modafinil—Diarrhoea—Docetaxel—prostate cancer	2.3e-05	0.000154	CcSEcCtD
Modafinil—Body temperature increased—Prednisone—prostate cancer	2.29e-05	0.000153	CcSEcCtD
Modafinil—Abdominal pain—Prednisone—prostate cancer	2.29e-05	0.000153	CcSEcCtD
Modafinil—Confusional state—Epirubicin—prostate cancer	2.29e-05	0.000153	CcSEcCtD
Modafinil—Phenoxybenzamine—CYP3A4—prostate cancer	2.28e-05	0.00633	CrCbGaD
Modafinil—Palpitations—Doxorubicin—prostate cancer	2.27e-05	0.000152	CcSEcCtD
Modafinil—Anaphylactic shock—Epirubicin—prostate cancer	2.27e-05	0.000152	CcSEcCtD
Modafinil—Oedema—Epirubicin—prostate cancer	2.27e-05	0.000152	CcSEcCtD
Modafinil—Loss of consciousness—Doxorubicin—prostate cancer	2.26e-05	0.000151	CcSEcCtD
Modafinil—Infection—Epirubicin—prostate cancer	2.25e-05	0.000151	CcSEcCtD
Modafinil—Cough—Doxorubicin—prostate cancer	2.24e-05	0.00015	CcSEcCtD
Modafinil—Shock—Epirubicin—prostate cancer	2.23e-05	0.000149	CcSEcCtD
Modafinil—Convulsion—Doxorubicin—prostate cancer	2.23e-05	0.000149	CcSEcCtD
Modafinil—Diarrhoea—Capecitabine—prostate cancer	2.23e-05	0.000149	CcSEcCtD
Modafinil—Nervous system disorder—Epirubicin—prostate cancer	2.22e-05	0.000149	CcSEcCtD
Modafinil—Dizziness—Docetaxel—prostate cancer	2.22e-05	0.000149	CcSEcCtD
Modafinil—Hypertension—Doxorubicin—prostate cancer	2.22e-05	0.000148	CcSEcCtD
Modafinil—Tachycardia—Epirubicin—prostate cancer	2.21e-05	0.000148	CcSEcCtD
Modafinil—Skin disorder—Epirubicin—prostate cancer	2.2e-05	0.000147	CcSEcCtD
Modafinil—Hyperhidrosis—Epirubicin—prostate cancer	2.19e-05	0.000147	CcSEcCtD
Modafinil—Myalgia—Doxorubicin—prostate cancer	2.19e-05	0.000146	CcSEcCtD
Modafinil—Chest pain—Doxorubicin—prostate cancer	2.19e-05	0.000146	CcSEcCtD
Modafinil—Arthralgia—Doxorubicin—prostate cancer	2.19e-05	0.000146	CcSEcCtD
Modafinil—Anxiety—Doxorubicin—prostate cancer	2.18e-05	0.000146	CcSEcCtD
Modafinil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	2.17e-05	0.000145	CcSEcCtD
Modafinil—Discomfort—Doxorubicin—prostate cancer	2.16e-05	0.000145	CcSEcCtD
Modafinil—Anorexia—Epirubicin—prostate cancer	2.16e-05	0.000144	CcSEcCtD
Modafinil—Dizziness—Capecitabine—prostate cancer	2.15e-05	0.000144	CcSEcCtD
Modafinil—Dry mouth—Doxorubicin—prostate cancer	2.14e-05	0.000143	CcSEcCtD
Modafinil—Vomiting—Docetaxel—prostate cancer	2.14e-05	0.000143	CcSEcCtD
Modafinil—Hypersensitivity—Prednisone—prostate cancer	2.14e-05	0.000143	CcSEcCtD
Modafinil—Rash—Docetaxel—prostate cancer	2.12e-05	0.000142	CcSEcCtD
Modafinil—Hypotension—Epirubicin—prostate cancer	2.12e-05	0.000142	CcSEcCtD
Modafinil—Dermatitis—Docetaxel—prostate cancer	2.12e-05	0.000142	CcSEcCtD
Modafinil—Confusional state—Doxorubicin—prostate cancer	2.12e-05	0.000141	CcSEcCtD
Modafinil—Headache—Docetaxel—prostate cancer	2.11e-05	0.000141	CcSEcCtD
Modafinil—Oedema—Doxorubicin—prostate cancer	2.1e-05	0.00014	CcSEcCtD
Modafinil—Anaphylactic shock—Doxorubicin—prostate cancer	2.1e-05	0.00014	CcSEcCtD
Modafinil—Infection—Doxorubicin—prostate cancer	2.09e-05	0.000139	CcSEcCtD
Modafinil—Asthenia—Prednisone—prostate cancer	2.08e-05	0.000139	CcSEcCtD
Modafinil—Vomiting—Capecitabine—prostate cancer	2.07e-05	0.000138	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Epirubicin—prostate cancer	2.07e-05	0.000138	CcSEcCtD
Modafinil—Shock—Doxorubicin—prostate cancer	2.06e-05	0.000138	CcSEcCtD
Modafinil—Nervous system disorder—Doxorubicin—prostate cancer	2.06e-05	0.000138	CcSEcCtD
Modafinil—Rash—Capecitabine—prostate cancer	2.05e-05	0.000137	CcSEcCtD
Modafinil—Pruritus—Prednisone—prostate cancer	2.05e-05	0.000137	CcSEcCtD
Modafinil—Insomnia—Epirubicin—prostate cancer	2.05e-05	0.000137	CcSEcCtD
Modafinil—Dermatitis—Capecitabine—prostate cancer	2.05e-05	0.000137	CcSEcCtD
Modafinil—Tachycardia—Doxorubicin—prostate cancer	2.05e-05	0.000137	CcSEcCtD
Modafinil—Headache—Capecitabine—prostate cancer	2.04e-05	0.000136	CcSEcCtD
Modafinil—Skin disorder—Doxorubicin—prostate cancer	2.04e-05	0.000136	CcSEcCtD
Modafinil—Paraesthesia—Epirubicin—prostate cancer	2.04e-05	0.000136	CcSEcCtD
Modafinil—Hyperhidrosis—Doxorubicin—prostate cancer	2.03e-05	0.000136	CcSEcCtD
Modafinil—Dyspnoea—Epirubicin—prostate cancer	2.02e-05	0.000135	CcSEcCtD
Modafinil—Somnolence—Epirubicin—prostate cancer	2.02e-05	0.000135	CcSEcCtD
Modafinil—Anorexia—Doxorubicin—prostate cancer	2e-05	0.000134	CcSEcCtD
Modafinil—Nausea—Docetaxel—prostate cancer	2e-05	0.000133	CcSEcCtD
Modafinil—Dyspepsia—Epirubicin—prostate cancer	2e-05	0.000133	CcSEcCtD
Modafinil—Diarrhoea—Prednisone—prostate cancer	1.98e-05	0.000133	CcSEcCtD
Modafinil—Decreased appetite—Epirubicin—prostate cancer	1.97e-05	0.000132	CcSEcCtD
Modafinil—Hypotension—Doxorubicin—prostate cancer	1.96e-05	0.000131	CcSEcCtD
Modafinil—Gastrointestinal disorder—Epirubicin—prostate cancer	1.96e-05	0.000131	CcSEcCtD
Modafinil—Fatigue—Epirubicin—prostate cancer	1.96e-05	0.000131	CcSEcCtD
Modafinil—Pain—Epirubicin—prostate cancer	1.94e-05	0.00013	CcSEcCtD
Modafinil—Constipation—Epirubicin—prostate cancer	1.94e-05	0.00013	CcSEcCtD
Modafinil—Nausea—Capecitabine—prostate cancer	1.93e-05	0.000129	CcSEcCtD
Modafinil—Dizziness—Prednisone—prostate cancer	1.92e-05	0.000128	CcSEcCtD
Modafinil—Musculoskeletal discomfort—Doxorubicin—prostate cancer	1.91e-05	0.000128	CcSEcCtD
Modafinil—Insomnia—Doxorubicin—prostate cancer	1.9e-05	0.000127	CcSEcCtD
Modafinil—Paraesthesia—Doxorubicin—prostate cancer	1.88e-05	0.000126	CcSEcCtD
Modafinil—Dyspnoea—Doxorubicin—prostate cancer	1.87e-05	0.000125	CcSEcCtD
Modafinil—Feeling abnormal—Epirubicin—prostate cancer	1.87e-05	0.000125	CcSEcCtD
Modafinil—Somnolence—Doxorubicin—prostate cancer	1.87e-05	0.000125	CcSEcCtD
Modafinil—Gastrointestinal pain—Epirubicin—prostate cancer	1.85e-05	0.000124	CcSEcCtD
Modafinil—Dyspepsia—Doxorubicin—prostate cancer	1.85e-05	0.000123	CcSEcCtD
Modafinil—Methadone—CYP3A4—prostate cancer	1.85e-05	0.00512	CrCbGaD
Modafinil—Vomiting—Prednisone—prostate cancer	1.84e-05	0.000123	CcSEcCtD
Modafinil—Rash—Prednisone—prostate cancer	1.83e-05	0.000122	CcSEcCtD
Modafinil—Dermatitis—Prednisone—prostate cancer	1.83e-05	0.000122	CcSEcCtD
Modafinil—Decreased appetite—Doxorubicin—prostate cancer	1.82e-05	0.000122	CcSEcCtD
Modafinil—Headache—Prednisone—prostate cancer	1.82e-05	0.000121	CcSEcCtD
Modafinil—Gastrointestinal disorder—Doxorubicin—prostate cancer	1.81e-05	0.000121	CcSEcCtD
Modafinil—Fatigue—Doxorubicin—prostate cancer	1.81e-05	0.000121	CcSEcCtD
Modafinil—Orphenadrine—CYP3A4—prostate cancer	1.81e-05	0.00502	CrCbGaD
Modafinil—Urticaria—Epirubicin—prostate cancer	1.8e-05	0.00012	CcSEcCtD
Modafinil—Pain—Doxorubicin—prostate cancer	1.79e-05	0.00012	CcSEcCtD
Modafinil—Constipation—Doxorubicin—prostate cancer	1.79e-05	0.00012	CcSEcCtD
Modafinil—Abdominal pain—Epirubicin—prostate cancer	1.79e-05	0.00012	CcSEcCtD
Modafinil—Body temperature increased—Epirubicin—prostate cancer	1.79e-05	0.00012	CcSEcCtD
Modafinil—Feeling abnormal—Doxorubicin—prostate cancer	1.73e-05	0.000116	CcSEcCtD
Modafinil—Nausea—Prednisone—prostate cancer	1.72e-05	0.000115	CcSEcCtD
Modafinil—Gastrointestinal pain—Doxorubicin—prostate cancer	1.72e-05	0.000115	CcSEcCtD
Modafinil—Hypersensitivity—Epirubicin—prostate cancer	1.67e-05	0.000112	CcSEcCtD
Modafinil—Urticaria—Doxorubicin—prostate cancer	1.67e-05	0.000111	CcSEcCtD
Modafinil—Body temperature increased—Doxorubicin—prostate cancer	1.66e-05	0.000111	CcSEcCtD
Modafinil—Abdominal pain—Doxorubicin—prostate cancer	1.66e-05	0.000111	CcSEcCtD
Modafinil—Asthenia—Epirubicin—prostate cancer	1.63e-05	0.000109	CcSEcCtD
Modafinil—Pruritus—Epirubicin—prostate cancer	1.6e-05	0.000107	CcSEcCtD
Modafinil—Diarrhoea—Epirubicin—prostate cancer	1.55e-05	0.000104	CcSEcCtD
Modafinil—Hypersensitivity—Doxorubicin—prostate cancer	1.55e-05	0.000103	CcSEcCtD
Modafinil—Asthenia—Doxorubicin—prostate cancer	1.51e-05	0.000101	CcSEcCtD
Modafinil—Dizziness—Epirubicin—prostate cancer	1.5e-05	0.0001	CcSEcCtD
Modafinil—Pruritus—Doxorubicin—prostate cancer	1.48e-05	9.92e-05	CcSEcCtD
Modafinil—Vomiting—Epirubicin—prostate cancer	1.44e-05	9.64e-05	CcSEcCtD
Modafinil—Diarrhoea—Doxorubicin—prostate cancer	1.44e-05	9.59e-05	CcSEcCtD
Modafinil—Rash—Epirubicin—prostate cancer	1.43e-05	9.56e-05	CcSEcCtD
Modafinil—Dermatitis—Epirubicin—prostate cancer	1.43e-05	9.55e-05	CcSEcCtD
Modafinil—Headache—Epirubicin—prostate cancer	1.42e-05	9.49e-05	CcSEcCtD
Modafinil—Dizziness—Doxorubicin—prostate cancer	1.39e-05	9.27e-05	CcSEcCtD
Modafinil—Nausea—Epirubicin—prostate cancer	1.35e-05	9e-05	CcSEcCtD
Modafinil—Vomiting—Doxorubicin—prostate cancer	1.33e-05	8.92e-05	CcSEcCtD
Modafinil—Rash—Doxorubicin—prostate cancer	1.32e-05	8.84e-05	CcSEcCtD
Modafinil—Dermatitis—Doxorubicin—prostate cancer	1.32e-05	8.83e-05	CcSEcCtD
Modafinil—Headache—Doxorubicin—prostate cancer	1.31e-05	8.79e-05	CcSEcCtD
Modafinil—Nausea—Doxorubicin—prostate cancer	1.25e-05	8.33e-05	CcSEcCtD
Modafinil—CYP2B6—Metabolism—CYP1A1—prostate cancer	3.03e-06	3.63e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2C19—prostate cancer	3.02e-06	3.63e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP1B1—prostate cancer	3.02e-06	3.62e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—ERCC2—prostate cancer	3e-06	3.6e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—SLC5A5—prostate cancer	2.97e-06	3.56e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTA1—prostate cancer	2.97e-06	3.56e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CYP1A1—prostate cancer	2.96e-06	3.55e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTT1—prostate cancer	2.95e-06	3.54e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ACHE—prostate cancer	2.95e-06	3.54e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTO1—prostate cancer	2.94e-06	3.52e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HSD3B2—prostate cancer	2.94e-06	3.52e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NAT2—prostate cancer	2.94e-06	3.52e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—ERCC2—prostate cancer	2.93e-06	3.52e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GGT1—prostate cancer	2.92e-06	3.51e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2A6—prostate cancer	2.92e-06	3.5e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—HIF1A—prostate cancer	2.91e-06	3.49e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.91e-06	3.49e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP2E1—prostate cancer	2.9e-06	3.48e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NCOA1—prostate cancer	2.88e-06	3.45e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NQO1—prostate cancer	2.87e-06	3.44e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—LEP—prostate cancer	2.84e-06	3.4e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKR1C3—prostate cancer	2.84e-06	3.4e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP19A1—prostate cancer	2.84e-06	3.4e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—TH—prostate cancer	2.83e-06	3.39e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PRKACB—prostate cancer	2.82e-06	3.39e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—MTHFR—prostate cancer	2.82e-06	3.38e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2C18—prostate cancer	2.82e-06	3.38e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PLCB2—prostate cancer	2.82e-06	3.38e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—LRP2—prostate cancer	2.82e-06	3.38e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CAV1—prostate cancer	2.81e-06	3.37e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.81e-06	3.37e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP3A4—prostate cancer	2.8e-06	3.36e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP17A1—prostate cancer	2.79e-06	3.35e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.78e-06	3.34e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KDR—prostate cancer	2.78e-06	3.34e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PPARA—prostate cancer	2.77e-06	3.32e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—P4HB—prostate cancer	2.76e-06	3.31e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—MTHFR—prostate cancer	2.76e-06	3.31e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.76e-06	3.3e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP1B1—prostate cancer	2.75e-06	3.3e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—RXRA—prostate cancer	2.74e-06	3.28e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ESR1—prostate cancer	2.71e-06	3.25e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PPARA—prostate cancer	2.71e-06	3.25e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC22A1—prostate cancer	2.69e-06	3.22e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GGT1—prostate cancer	2.67e-06	3.2e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.66e-06	3.19e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NCOA2—prostate cancer	2.66e-06	3.19e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—BAD—prostate cancer	2.65e-06	3.17e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—COMT—prostate cancer	2.64e-06	3.16e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTP1—prostate cancer	2.63e-06	3.15e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NCOA1—prostate cancer	2.63e-06	3.15e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SULT2A1—prostate cancer	2.62e-06	3.14e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CAV1—prostate cancer	2.6e-06	3.12e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP19A1—prostate cancer	2.59e-06	3.1e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ITPR1—prostate cancer	2.58e-06	3.1e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MED12—prostate cancer	2.58e-06	3.09e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CG—prostate cancer	2.56e-06	3.07e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—APC—prostate cancer	2.56e-06	3.07e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GNG5—prostate cancer	2.56e-06	3.06e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CAV1—prostate cancer	2.54e-06	3.05e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.54e-06	3.05e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—SLC5A5—prostate cancer	2.54e-06	3.05e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IRS1—prostate cancer	2.53e-06	3.04e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EGF—prostate cancer	2.53e-06	3.04e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—RXRA—prostate cancer	2.5e-06	2.99e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP2E1—prostate cancer	2.48e-06	2.97e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NCOA3—prostate cancer	2.46e-06	2.95e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—GSK3B—prostate cancer	2.46e-06	2.95e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NQO1—prostate cancer	2.45e-06	2.94e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—TYMS—prostate cancer	2.44e-06	2.93e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.43e-06	2.91e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—INS—prostate cancer	2.43e-06	2.91e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—TH—prostate cancer	2.42e-06	2.9e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—GSTM1—prostate cancer	2.41e-06	2.89e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—COMT—prostate cancer	2.41e-06	2.88e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.4e-06	2.88e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTP1—prostate cancer	2.39e-06	2.87e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP3A4—prostate cancer	2.39e-06	2.87e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.38e-06	2.85e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CREBBP—prostate cancer	2.38e-06	2.85e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CG—prostate cancer	2.37e-06	2.84e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—LPL—prostate cancer	2.37e-06	2.84e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ITPR1—prostate cancer	2.36e-06	2.83e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP1B1—prostate cancer	2.35e-06	2.82e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—HPGDS—prostate cancer	2.35e-06	2.82e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IGF1—prostate cancer	2.35e-06	2.81e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—EGFR—prostate cancer	2.33e-06	2.8e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2C19—prostate cancer	2.33e-06	2.8e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CG—prostate cancer	2.32e-06	2.78e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.32e-06	2.78e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CYP1A1—prostate cancer	2.29e-06	2.74e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTT1—prostate cancer	2.28e-06	2.73e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ACHE—prostate cancer	2.28e-06	2.73e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GGT1—prostate cancer	2.28e-06	2.73e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—ERCC2—prostate cancer	2.27e-06	2.72e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MAP2K1—prostate cancer	2.27e-06	2.72e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CD—prostate cancer	2.25e-06	2.7e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2A6—prostate cancer	2.25e-06	2.7e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—INS—prostate cancer	2.24e-06	2.69e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NCOA1—prostate cancer	2.24e-06	2.69e-05	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—PIK3CA—prostate cancer	2.23e-06	2.68e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SERPINE1—prostate cancer	2.23e-06	2.67e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—TYMS—prostate cancer	2.23e-06	2.67e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP19A1—prostate cancer	2.21e-06	2.65e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—KRAS—prostate cancer	2.21e-06	2.64e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—GSTM1—prostate cancer	2.2e-06	2.64e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—CREBBP—prostate cancer	2.2e-06	2.64e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—INS—prostate cancer	2.19e-06	2.63e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKR1C3—prostate cancer	2.19e-06	2.63e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PRKACB—prostate cancer	2.18e-06	2.61e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—LPL—prostate cancer	2.16e-06	2.59e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—FGF2—prostate cancer	2.16e-06	2.59e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP17A1—prostate cancer	2.16e-06	2.59e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—CREBBP—prostate cancer	2.15e-06	2.58e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—RXRA—prostate cancer	2.13e-06	2.56e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—MTHFR—prostate cancer	2.13e-06	2.56e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—NOS3—prostate cancer	2.13e-06	2.55e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PPARA—prostate cancer	2.09e-06	2.51e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CYP1A1—prostate cancer	2.09e-06	2.5e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CD—prostate cancer	2.08e-06	2.5e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.08e-06	2.49e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—ERCC2—prostate cancer	2.07e-06	2.48e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—JAK2—prostate cancer	2.07e-06	2.48e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—COMT—prostate cancer	2.06e-06	2.47e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NCOA2—prostate cancer	2.05e-06	2.46e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTP1—prostate cancer	2.05e-06	2.45e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CD—prostate cancer	2.04e-06	2.44e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—PIK3CA—prostate cancer	2.03e-06	2.43e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MDM2—prostate cancer	2.02e-06	2.42e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ITPR1—prostate cancer	2.01e-06	2.41e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—ERBB2—prostate cancer	1.99e-06	2.39e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.98e-06	2.37e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—NOS3—prostate cancer	1.97e-06	2.36e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CAV1—prostate cancer	1.97e-06	2.36e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CB—prostate cancer	1.96e-06	2.35e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.96e-06	2.35e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—MTHFR—prostate cancer	1.94e-06	2.33e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—NOS3—prostate cancer	1.92e-06	2.31e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.91e-06	2.3e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PPARA—prostate cancer	1.91e-06	2.29e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—TYMS—prostate cancer	1.9e-06	2.28e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NQO1—prostate cancer	1.89e-06	2.27e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CXCL8—prostate cancer	1.89e-06	2.26e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—GSTM1—prostate cancer	1.88e-06	2.25e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.88e-06	2.25e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—TH—prostate cancer	1.87e-06	2.24e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—LPL—prostate cancer	1.85e-06	2.21e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN1B—prostate cancer	1.84e-06	2.21e-05	CbGpPWpGaD
Modafinil—ADRA1B—GPCR downstream signaling—AKT1—prostate cancer	1.82e-06	2.19e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CB—prostate cancer	1.82e-06	2.18e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.81e-06	2.18e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CASP3—prostate cancer	1.81e-06	2.17e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL2—prostate cancer	1.8e-06	2.16e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTGS2—prostate cancer	1.8e-06	2.16e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—IL6—prostate cancer	1.79e-06	2.15e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CAV1—prostate cancer	1.79e-06	2.15e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.79e-06	2.15e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.78e-06	2.14e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.78e-06	2.13e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—ERCC2—prostate cancer	1.77e-06	2.12e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTGS2—prostate cancer	1.76e-06	2.11e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GGT1—prostate cancer	1.76e-06	2.11e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CCND1—prostate cancer	1.76e-06	2.11e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CTNNB1—prostate cancer	1.74e-06	2.09e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NCOA1—prostate cancer	1.73e-06	2.08e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.71e-06	2.05e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MMP9—prostate cancer	1.71e-06	2.05e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.71e-06	2.05e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—CDKN1A—prostate cancer	1.7e-06	2.04e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PTEN—prostate cancer	1.7e-06	2.03e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—INS—prostate cancer	1.7e-06	2.03e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—MTHFR—prostate cancer	1.66e-06	1.99e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—CREBBP—prostate cancer	1.66e-06	1.99e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling by GPCR—AKT1—prostate cancer	1.65e-06	1.98e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—RXRA—prostate cancer	1.65e-06	1.97e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CG—prostate cancer	1.63e-06	1.96e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PPARA—prostate cancer	1.63e-06	1.95e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EP300—prostate cancer	1.62e-06	1.94e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—COMT—prostate cancer	1.59e-06	1.9e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTP1—prostate cancer	1.58e-06	1.89e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.57e-06	1.89e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—SRC—prostate cancer	1.57e-06	1.89e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PTEN—prostate cancer	1.57e-06	1.88e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ITPR1—prostate cancer	1.55e-06	1.86e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—INS—prostate cancer	1.55e-06	1.85e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PTEN—prostate cancer	1.53e-06	1.84e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CAV1—prostate cancer	1.53e-06	1.84e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—VEGFA—prostate cancer	1.53e-06	1.84e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—STAT3—prostate cancer	1.52e-06	1.82e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—CREBBP—prostate cancer	1.51e-06	1.82e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—EP300—prostate cancer	1.5e-06	1.8e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—NOS3—prostate cancer	1.49e-06	1.78e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—TYMS—prostate cancer	1.47e-06	1.76e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.46e-06	1.76e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—EP300—prostate cancer	1.46e-06	1.75e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—GSTM1—prostate cancer	1.45e-06	1.74e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CD—prostate cancer	1.44e-06	1.72e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—LPL—prostate cancer	1.42e-06	1.71e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—MYC—prostate cancer	1.41e-06	1.69e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TGFB1—prostate cancer	1.41e-06	1.69e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CG—prostate cancer	1.4e-06	1.67e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—EGFR—prostate cancer	1.38e-06	1.65e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CYP1A1—prostate cancer	1.38e-06	1.65e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CB—prostate cancer	1.37e-06	1.65e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—ERCC2—prostate cancer	1.36e-06	1.64e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTGS2—prostate cancer	1.36e-06	1.63e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—NOS3—prostate cancer	1.36e-06	1.63e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—INS—prostate cancer	1.32e-06	1.58e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—KRAS—prostate cancer	1.3e-06	1.56e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—CREBBP—prostate cancer	1.29e-06	1.55e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—MTHFR—prostate cancer	1.28e-06	1.54e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PPARA—prostate cancer	1.26e-06	1.51e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CB—prostate cancer	1.25e-06	1.5e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTGS2—prostate cancer	1.24e-06	1.49e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CD—prostate cancer	1.23e-06	1.47e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—PIK3CA—prostate cancer	1.2e-06	1.44e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PTEN—prostate cancer	1.19e-06	1.42e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CAV1—prostate cancer	1.18e-06	1.42e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—NOS3—prostate cancer	1.16e-06	1.39e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—TP53—prostate cancer	1.16e-06	1.39e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—EP300—prostate cancer	1.13e-06	1.36e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—PIK3CA—prostate cancer	1.11e-06	1.33e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—PIK3CA—prostate cancer	1.08e-06	1.3e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PTEN—prostate cancer	1.08e-06	1.3e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CG—prostate cancer	1.08e-06	1.29e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CB—prostate cancer	1.07e-06	1.28e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTGS2—prostate cancer	1.06e-06	1.27e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—IL6—prostate cancer	1.06e-06	1.27e-05	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—EP300—prostate cancer	1.03e-06	1.24e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—INS—prostate cancer	1.02e-06	1.22e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—CREBBP—prostate cancer	9.99e-07	1.2e-05	CbGpPWpGaD
Modafinil—ADRA1B—Signaling Pathways—AKT1—prostate cancer	9.78e-07	1.17e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CD—prostate cancer	9.47e-07	1.14e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PTEN—prostate cancer	9.24e-07	1.11e-05	CbGpPWpGaD
Modafinil—CYP2B6—Metabolism—AKT1—prostate cancer	9.05e-07	1.08e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—NOS3—prostate cancer	8.94e-07	1.07e-05	CbGpPWpGaD
Modafinil—CYP3A5—Metabolism—AKT1—prostate cancer	8.84e-07	1.06e-05	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—EP300—prostate cancer	8.81e-07	1.06e-05	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—PIK3CA—prostate cancer	8.37e-07	1e-05	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CB—prostate cancer	8.26e-07	9.9e-06	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTGS2—prostate cancer	8.18e-07	9.81e-06	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—PIK3CA—prostate cancer	7.63e-07	9.15e-06	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PTEN—prostate cancer	7.13e-07	8.55e-06	CbGpPWpGaD
Modafinil—CYP2C19—Metabolism—AKT1—prostate cancer	6.84e-07	8.2e-06	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—EP300—prostate cancer	6.8e-07	8.16e-06	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—PIK3CA—prostate cancer	6.52e-07	7.82e-06	CbGpPWpGaD
Modafinil—CYP2C9—Metabolism—AKT1—prostate cancer	6.23e-07	7.48e-06	CbGpPWpGaD
Modafinil—CYP1A2—Metabolism—AKT1—prostate cancer	5.33e-07	6.39e-06	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—PIK3CA—prostate cancer	5.03e-07	6.04e-06	CbGpPWpGaD
Modafinil—CYP3A4—Metabolism—AKT1—prostate cancer	4.11e-07	4.93e-06	CbGpPWpGaD
